Vimarsana
Biggest News Aggregation in the World

Cocoon Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cocoon Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cocoon Platform Today - Breaking & Trending Today

Lonza and Agilent Collaborate on New Analytical Technologies and Tools - Vimarsana News

Lonza and Agilent Collaborate on New Analytical Technologies and Tools

Incorporation of Agilent’s analytical technologies into Lonza’s Cocoon® platform will improve quality and consistency, leading to increased access to personalized medicines, according to officials at both companies. Collaboration aims to develop and integrate current and new analytical technologies into patient-scale cell therapy manufacturing workflows with the Cocoon Platform. The companies also aim to define the ideal Critical Quality Attributes required for cell therapies.

Leucid Bio and Lonza Enter Strategic Collaboration to Leverage the Cocoon® Platform for Automated Manufacturing of Personalised CAR T-Cells - Vimarsana News

Leucid Bio and Lonza Enter Strategic Collaboration to Leverage the Cocoon® Platform for Automated Manufacturing of Personalised CAR T-Cells

/PRNewswire/ -- Leucid Bio ("Leucid" or the "Company"), a biotech company pioneering next-generation cell therapies for hard-to-treat cancers, today announces...

Leucid Bio and Lonza Enter Strategic Collaboration to Leverage the Cocoon Platform for Automated Manufacturing of Personalised CAR T-Cells - Vimarsana News

Leucid Bio and Lonza Enter Strategic Collaboration to Leverage the Cocoon Platform for Automated Manufacturing of Personalised CAR T-Cells

- Leucid will work with Lonza on the Cocoon Platform for Leucid Bio's Phase I/II clinical studies with its lead candidate, LEU-011, for the treatment of platinum resistant ovarian cancer -

Leucid Bio and Lonza Enter Strategic Collaboration to Leverage the Cocoon® Platform for Automated Manufacturing of Personalised CAR T-Cells - Vimarsana News

Leucid Bio and Lonza Enter Strategic Collaboration to Leverage the Cocoon® Platform for Automated Manufacturing of Personalised CAR T-Cells

/PRNewswire/ -- Leucid Bio ("Leucid" or the "Company"), a biotech company pioneering next-generation cell therapies for hard-to-treat cancers, today announces...